ECPI PHARMACOLOGY EXAM 1 QUIZZES WITH
100% CORRECT ANSWERS.
receptor,subtype,located,in,all,autonomic,nervous,system,ganglia,and,in,the,adrena
l,medulla,,ANS,,NicotinicN
receptor,that,stimulates,parasympathetic,and,sympathetic,postganglionic,nerves,an
d,releases,epinephr ine,form,the,adrenal,medulla,,ANS,-,NicotinicN
receptor,subtype,located,in,the,neuromuscular,junction,,ANS,-,NicotinicM
receptor,that,causes,contraction,of,skeletal,muscle,,ANS,-,NicotinicM
receptor,subtype,that,targets,parasympathetic,organs,,ANS,-,Muscarinic
receptor,subtype,that,is,located,in,the,eye,,heart,,lungs,,bladder,,GI,Tract,,sweat,gla
nds,,sex,organs,,an d,blood,vessels,,ANS,-,Muscarinic
when,activated,,this,receptor,subtype,causes,coordinated,contraction,of,detrusor,an
d,relaxation,of,the,
trigone,and,sphincter,which,causes,voiding,of,the,bladder,,ANS,-,Muscarinic
receptor,subtype,that,causes,vasodilation,of,the,blood,vessels,,ANS,-,Muscarinic
receptor,that,causes,constriction,of,bronchi,,ANS,-,Muscarinic
NicotinicN,,NicotinicM,,and,Muscarinic,are,all,_______,receptor,subtypes,,ANS,-,cholin
ergic
decreased,pupil,diameter,,ANS,-,miosis
ECPI PHARMACOLOGY EXAM 1
, ECPI
increased,pupil,size,,ANS,-,mydriasis
receptor,subtype,that,causes,mydriasis,,arteriole,constriction,in,the,skin,,viscera,,an
d,mucous,membran
es,,ejaculation,,contraction,of,the,prostatic,capsule,,and,contraction,of,the,trigone,a
nd,bladder,sphinct er,,ANS,-,Alpha1
receptor,subtype,leads,to,Inhibition,of,transmitter,release,in,presynaptic,nerve,termi
nals,,ANS,-,Alpha2
receptor,subtype,that,leads,to,increased,HR,,force,of,contraction,,speed,of,AV,condu
ction,,and,causes,t he,release,of,renin,in,the,kidneys,,ANS,-,Beta1
receptor,subtype,that,causes,dilation,of,arterioles,in,the,heart,,lungs,,and,skeletal,m
uscles,,bronchial,di
lation,,uterine,relaxation,,glycogenolysis,,and,enhanced,contraction,of,skeletal,musc
les,,ANS,-,Beta2
receptor,subtype,that,effects,the,kidney,by,dilating,its,vasculature,,ANS,-,Dopamine
alpha1,,alpha2,,beta1,,beta2,,and,dopamine,are,all,_____,receptor,subtypes,,ANS,-,a
drenergic
medication,used,to,treat,non-obstructive,urinary,retention,,ANS,-,Bethanechol
medication,that's,investigational,use,is,to,treat,gastroesophageal,reflux,,ANS,-,Beth
anechol
medication,shouldn't,be,used,with,someone,who,has,latent,or,active,asthma,,becau
se,it,causes,bronchi al,constriction,,ANS,-,Bethanechol
med,that,should,be,taken,without,food,(to,avoid,nausea/
vomiting),,so,administered,1,hour,before,mea
ls,or,2,hours,after,meals,,ANS,-,Bethanechol
ECPI PHARMACOLOGY EXAM 1